| Product Code: ETC9976396 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the United States continued to rely on imports for small volume parenteral products, with Switzerland, Ireland, India, Italy, and Singapore being the top exporting countries. Despite the low concentration of the Herfindahl-Hirschman Index (HHI), the market experienced a decline in compound annual growth rate (CAGR) from 2020-2024 at -4.13%. Furthermore, the growth rate from 2023-2024 saw a significant decrease of -38.1%, indicating a challenging year for small volume parenteral import shipments to the USA.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Small Volume Parenteral Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Small Volume Parenteral Market Revenues & Volume, 2022 & 2032F |
3.3 United States (US) Small Volume Parenteral Market - Industry Life Cycle |
3.4 United States (US) Small Volume Parenteral Market - Porter's Five Forces |
3.5 United States (US) Small Volume Parenteral Market Revenues & Volume Share, By Form, 2022 & 2032F |
3.6 United States (US) Small Volume Parenteral Market Revenues & Volume Share, By Dose Type, 2022 & 2032F |
3.7 United States (US) Small Volume Parenteral Market Revenues & Volume Share, By Packaging, 2022 & 2032F |
3.8 United States (US) Small Volume Parenteral Market Revenues & Volume Share, By Indication, 2022 & 2032F |
4 United States (US) Small Volume Parenteral Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring parenteral administration of medications |
4.2.2 Growing demand for home healthcare services |
4.2.3 Technological advancements in manufacturing processes leading to cost efficiency and quality improvement |
4.3 Market Restraints |
4.3.1 Stringent regulations regarding the manufacturing and distribution of parenteral products |
4.3.2 High risk of contamination and infection associated with parenteral administration |
4.3.3 Limited shelf-life of small volume parenteral products leading to wastage |
5 United States (US) Small Volume Parenteral Market Trends |
6 United States (US) Small Volume Parenteral Market, By Types |
6.1 United States (US) Small Volume Parenteral Market, By Form |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Small Volume Parenteral Market Revenues & Volume, By Form, 2022 - 2032F |
6.1.3 United States (US) Small Volume Parenteral Market Revenues & Volume, By Liquid, 2022 - 2032F |
6.1.4 United States (US) Small Volume Parenteral Market Revenues & Volume, By Dry, 2022 - 2032F |
6.2 United States (US) Small Volume Parenteral Market, By Dose Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Small Volume Parenteral Market Revenues & Volume, By Single-dose, 2022 - 2032F |
6.2.3 United States (US) Small Volume Parenteral Market Revenues & Volume, By Multiple-dose, 2022 - 2032F |
6.3 United States (US) Small Volume Parenteral Market, By Packaging |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Small Volume Parenteral Market Revenues & Volume, By Ampoules, 2022 - 2032F |
6.3.3 United States (US) Small Volume Parenteral Market Revenues & Volume, By Vials, 2022 - 2032F |
6.3.4 United States (US) Small Volume Parenteral Market Revenues & Volume, By Pre-filled Syringes, 2022 - 2032F |
6.3.5 United States (US) Small Volume Parenteral Market Revenues & Volume, By Cartridges, 2022 - 2032F |
6.3.6 United States (US) Small Volume Parenteral Market Revenues & Volume, By Bottles, 2022 - 2032F |
6.3.7 United States (US) Small Volume Parenteral Market Revenues & Volume, By Others, 2022 - 2032F |
6.4 United States (US) Small Volume Parenteral Market, By Indication |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Small Volume Parenteral Market Revenues & Volume, By Pain Management, 2022 - 2032F |
6.4.3 United States (US) Small Volume Parenteral Market Revenues & Volume, By Cancer Care, 2022 - 2032F |
6.4.4 United States (US) Small Volume Parenteral Market Revenues & Volume, By Malnourishment, 2022 - 2032F |
6.4.5 United States (US) Small Volume Parenteral Market Revenues & Volume, By Diabetes, 2022 - 2032F |
6.4.6 United States (US) Small Volume Parenteral Market Revenues & Volume, By Others, 2022 - 2032F |
7 United States (US) Small Volume Parenteral Market Import-Export Trade Statistics |
7.1 United States (US) Small Volume Parenteral Market Export to Major Countries |
7.2 United States (US) Small Volume Parenteral Market Imports from Major Countries |
8 United States (US) Small Volume Parenteral Market Key Performance Indicators |
8.1 Percentage of small volume parenteral products distributed through home healthcare services |
8.2 Adoption rate of advanced manufacturing technologies in the production of small volume parenteral products |
8.3 Rate of compliance with regulatory standards for small volume parenteral products |
9 United States (US) Small Volume Parenteral Market - Opportunity Assessment |
9.1 United States (US) Small Volume Parenteral Market Opportunity Assessment, By Form, 2022 & 2032F |
9.2 United States (US) Small Volume Parenteral Market Opportunity Assessment, By Dose Type, 2022 & 2032F |
9.3 United States (US) Small Volume Parenteral Market Opportunity Assessment, By Packaging, 2022 & 2032F |
9.4 United States (US) Small Volume Parenteral Market Opportunity Assessment, By Indication, 2022 & 2032F |
10 United States (US) Small Volume Parenteral Market - Competitive Landscape |
10.1 United States (US) Small Volume Parenteral Market Revenue Share, By Companies, 2025 |
10.2 United States (US) Small Volume Parenteral Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here